Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Eye Tracking Experimental Studies To Explore Consumer Use of Food Labeling Information and Consumer Response to Online Surveys, 40153-40156 [2013-16001]
Download as PDF
Federal Register / Vol. 78, No. 128 / Wednesday, July 3, 2013 / Notices
original and two copies) to the following
address only: NIOSH Docket 229–A c/o
Zaida Burgos, Committee Management
Specialist, National Institute for
Occupational Safety and Health, Center
for Disease Control and Prevention,
1600 Clifton Road NE., M/S E–20,
Atlanta, Georgia 30333. Telephone and
facsimile submissions cannot be
accepted. For further information
contact: Paul Middendorf, Senior Health
Scientist, 1600 Clifton Rd. NE., MS: E–
20, Atlanta, GA 30239; telephone
(404)498–2500 (this is not a toll-free
number); email pmiddendorf@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elizabeth Millington,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2013–16015 Filed 7–2–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–N–0593]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Eye Tracking
Experimental Studies To Explore
Consumer Use of Food Labeling
Information and Consumer Response
to Online Surveys
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA or we) is
announcing that a proposed collection
of information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by August 2,
2013.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or emailed to
emcdonald on DSK67QTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
17:48 Jul 02, 2013
Jkt 229001
oira_submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–New and
title ‘‘Eye Tracking Experimental
Studies to Explore Consumer Use of
Food Labeling Information and
Consumer Response to Online Surveys.’’
Also include the FDA docket number
found in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT:
Domini Bean, Office of Information
Management, Food and Drug
Administration, 1350 Piccard Dr., PI50–
400T, Rockville, MD 20850,
domini.bean@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
Eye Tracking Experimental Studies To
Explore Consumer Use of Food Labeling
Information and Consumer Response to
Online Surveys—(OMB Control
Number 0910–NEW)
I. Background
Eye tracking is a consumer research
technique often used to determine
where a person is looking while
interacting with a visual display, such
as a product package and elements of
information on the package. The
technique collects eye movement data,
i.e., fixations and saccades (jumps of the
eye), which may be superimposed on
the display image to reveal: (1) Which
parts of the display captured the
viewer’s attention, (2) the order and
path in which visual elements were
seen, and (3) the length of time they
were viewed. These data provide
detailed information on what
individuals pay attention to on product
packages, how long they spend looking
at different package elements, and how
visual attention may be related to their
reaction to the images (Refs. 1 to 4, 7).
Data from eye tracking studies can also
help improve questionnaire design.
Different respondents may pay differing
degrees of attention to the elements of
a survey question or response options.
Eye tracking data can help to identify
the need and strategies for improving
the design (Refs. 5 and 6). Finally, eye
tracking data can provide information
on the decision strategies that
individuals use under different levels of
time pressure, which can help reveal the
influence of time on busy individuals’
food choices (Refs. 4 and 7).
As a public health agency, FDA helps
consumers make informed dietary
decisions by regulating nutrition
information on food labels, among other
activities. An understanding of how
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
40153
visual elements (e.g., labeling
statements such as claims, disclosure
statements, logos, and Nutrition Facts
label) influence consumers’ perceptions
and choices of products can assist us in
developing labeling information to help
consumers make informed dietary
decisions. In addition, we use selfadministered questionnaires in online
experimental studies to assess consumer
reactions to nutrition information on
food packages. An understanding of
how respondents react to survey
materials that are presented visually
will enhance our ability in collecting
better consumer data to help us fulfill
our missions.
The proposed data collection will use
eye tracking research to examine
consumers’ eye movements to achieve
three goals: (1) To better understand
consumer reaction to specific food
labeling information, (2) to better
understand survey respondent reaction
to specific survey questions related to
nutrition and health, and (3) to better
understand how time pressure
influences the priority and quality of
decision making and survey response.
In order to observe consumers’ eye
movement in different types of settings,
we propose to conduct two separate
studies, one in each of two different
settings. Study 1 is a laboratory study
that will ask participants to view on a
computer screen mockups of food labels
and perform tasks as well as answer
other survey questions. Study 2 is an instore study that will record eye
movement data from grocery shoppers
while they shop for preselected product
categories. The studies will use two
different survey instruments. Study
participants will come from two
separate convenience samples.
A. Study 1 (Laboratory Study)
Study 1 is a controlled randomized
experiment. It has two objectives. The
first objective is to collect data on how
consumers view and process label
information. The data will be used to
test the hypothesis that one or more
label and information characteristics
will cause variations in viewing and
processing. In this proposed study, we
will focus specifically on the following
characteristics: (1) Presence and type of
nutrition symbols, together with
presence of claims, on the Principal
Display Panel (PDP) of a conventional
food; (2) presence of a disclosure
statement (21 CFR 101.13(h)(1)–(3)) on
the PDP of a conventional food that
makes a nutrient content claim; (3)
format of the Nutrition Facts label on a
conventional food product; (4) presence
of a Dietary Supplement Health and
Education Act disclaimer on the PDP of
E:\FR\FM\03JYN1.SGM
03JYN1
40154
Federal Register / Vol. 78, No. 128 / Wednesday, July 3, 2013 / Notices
emcdonald on DSK67QTVN1PROD with NOTICES
a dietary supplement product that
makes a structure/function claim; (5)
presence and length of a qualified
health claim on the PDP of a dietary
supplement product; and (6) type of
product.
Label images will be created to allow
the study to focus on consumer reaction
to specific components of information
on a food label. All images will be
mockups resembling food labels that
may be found in the marketplace but
without any real or fictitious brand
name.
The second objective of Study 1 is to
examine how time pressure affects
information processing. We will use the
data to test the hypothesis that time
pressure will cause variations in
participant reactions (notice, attention,
use, perception, and intention) to
information. To test this hypothesis, the
study will, at certain selected questions,
expose participants to two randomly
assigned time conditions, such as no
time limit and 10 seconds per question.
The study will also include certain
questions selected from previous online
research we have sponsored in order to
examine which part(s) of a question or
which response options participants
notice and pay attention to when they
are asked to answer the question.
In the study, we plan to collect data
from 200 participants using a 15-minute
computer-assisted self-administered
questionnaire and a 5-minute debriefing
questionnaire. Forty interviews are
planned for each of 5 locations across
the contiguous 48 States. Participants
will be recruited from residents at each
location, and the study will aim to have
a reasonable degree of diversity in
participant gender, age, and education.
On a computer screen, participants will
first view a series of label images. Then
participants will answer a set of
questions related to their reactions to
the label images they see on the
computer screen. Each participant will
be randomly assigned to an
experimental condition that differs
primarily in label components and time
limit. To help understand the data, the
study will also collect information on
each participant’s background, such as
health status, label reading behavior,
and dietary preferences.
B. Study 2 (In-Store Study)
In Study 2, we plan to collect
observations of what information
grocery shoppers notice and pay
attention to while they do their
shopping in the store. The study will
gather eye movement data to provide an
indepth understanding of subconscious
and conscious factors that influence
food purchases. Specifically, the study
VerDate Mar<15>2010
17:48 Jul 02, 2013
Jkt 229001
will explore the role that the Principal
Display Panel and other label
information and components play in
purchase decisions. We will use the
data to test the hypotheses that product
familiarity or personal needs will cause
variations in information seeking and
that design elements (e.g., prominence,
text vs. graphics) will cause variations
in information seeking. To keep the
study within a manageable scope, only
shoppers who plan to shop for one or
more of preselected product categories
will be eligible to participate. Other
than product categories, however,
participants will not be restricted to
which products they examine, what
label information they view, or how
much time they spend in completing
any part of the study. To help
understand the data, the study will also
collect information on each participant’s
background, such as health status and
shopping practices. In Study 2 we plan
to collect data from 60 participants who
will each spend an average of 45
minutes in the study, including a
practice session, the shopping trip, and
a debriefing. The study will be
conducted in two different locations.
Participants will be recruited at
storefronts.
Both the laboratory study (Study 1)
and the in-store study (Study 2) are part
of our continuing effort to enable
consumers to make informed dietary
choices. We will use the studies to
assess consumer attention to and use of
various pieces of information on food
packages and the information’s
influence on product perceptions and
choices. The assessment will provide us
with background information to help
identify and develop more effective
labeling information and education in
the future. In addition, we will use data
from Study 1 to assess consumer
behaviors when they are asked to
respond to a sample of questions used
in the Agency’s consumer research. The
assessment will help enhance our
ability to conduct research that provides
useful information. Wherever possible,
we will also attempt to compare
findings from the two studies to assess
the degree to which results observed in
the laboratory reflect actual behaviors in
the market. For example, do laboratory
and in-store participants pay attention
to different labeling elements when they
make a shopping choice? Results of the
study will not be used to develop
population estimates.
In the Federal Register of June 15,
2012 (77 FR 35983), FDA published a
60-day notice requesting public
comment on the proposed collection of
information. We received three
comments. One comment addressed
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
matters that were outside the scope of
the information collection provisions
and will not be discussed here. We
respond to the remaining comments in
this document. For ease of reading, we
preface each comment with a numbered
‘‘Comment;’’ and each response by a
corresponding ‘‘Response.’’ We have
numbered each comment to help
distinguish between different topics.
The number assigned to each comment
is for organizational purposes only and
does not signify the comment’s value, or
importance, or the order in which it was
received.
(Comment 1) One comment
recommended that we examine the
accuracy of the eye tracking
methodology in identifying label
reading patterns before considering
applying the methodology more
broadly.
(Response) FDA agrees that it is
important to assess the degree of
accuracy the methodology can provide
and we have taken this into
consideration.
(Comment 2) One comment
questioned whether the use of eye
tracking methodology is essential to the
regulation of food labeling.
(Response) Part of our mission is to
help the public get accurate and
science-based information needed to use
foods to maintain and improve health
(Ref. 8). To help accomplish this
mission, we state in our 2011–2015
Strategic Plan that we will strengthen
social and behavioral sciences to help
consumers make informed decisions
about regulated products (Ref. 9). As
part of the strategy, the plan identifies
needs in knowing the audience,
ensuring audience understanding of
information, and evaluating
effectiveness of communication about
regulated products (Ref. 9). We will use
the proposed studies to assess consumer
attention to and use of various pieces of
information on food packages and the
information’s influence on product
perceptions and choices. These findings
can extend and compliment findings
from other consumer research FDA
conducts and help us identify and
develop more effective food labeling
information and education in the future.
Therefore, the use of eye tracking
methodology is valuable to our mission
in providing the public accurate and
science-based information.
(Comment 3) One comment
questioned the practical utility of the
information to be collected in the
proposed studies. The comment stated
that Study 1 would not yield nationally
representative results because it uses a
convenience sample and suggests this
limitation be noted in the supporting
E:\FR\FM\03JYN1.SGM
03JYN1
Federal Register / Vol. 78, No. 128 / Wednesday, July 3, 2013 / Notices
statement accompanying the Federal
Register 30-day notice. The comment
also questioned whether the sample size
of Study 2 (60 participants) would be
sufficient to yield detailed conclusions.
(Response) The 60-day notice stated
that the studies would not be used to
develop national estimates. We repeat
this statement in the supporting
statement. Though the sample size of
Study 2 is constrained by the available
resource, the study will provide
preliminary yet useful insights into
consumer viewing experiences with
food shopping.
(Comment 4) A comment asserted that
wearing eye tracking eyeglasses and a
headset for biometric measurement in
Study 2 would cause study subjects to
behave differently from how they shop
typically, thus weakening the reliability
of the data. Instead, the comment
suggests using a virtual store
methodology in a computer-assisted
central location test.
(Response) The comment did not
provide evidence to support its concern
or to illustrate the advantages of a
virtual store methodology over an eye
tracking methodology. Therefore,
because we do not have a sufficient
basis to conclude that the comment’s
suggested methodology would be better
suited for our purposes than the eye
tracking methodology described in the
60-day notice, we decline to change the
methodology for Study 2.
(Comment 5) A comment questioned
the use of the word ‘‘healthy’’ in certain
questions because the word has a
regulatory meaning and consumers may
not understand the regulatory criteria
for the claim ‘‘healthy.’’ The comment
suggested replacing ‘‘healthy’’ with
‘‘nutritious.’’ The comment also
expressed concern about questions that
ask participants their inferences about
the relationships between a product and
the risk of diabetes and obesity or
overweight. The comment reasoned that
these health conditions should not be
asked about because there are no current
authorized health claims permitted for
these conditions.
(Response) We disagree with the
comment. The studies are not to
examine whether or how consumers
understand labeling regulations. Rather,
part of the purpose of the studies is to
better understand how consumers infer
from labeling the characteristics of food
products. As stated in the comment,
consumers may not understand
regulatory criteria for claims, including
‘‘healthy,’’ and there are no authorized
health claims that link a food to diabetes
or obesity. Yet consumers make product
inferences and decisions based on their
own experiences and knowledge, with
or without any understanding about
labeling regulations. Hence, for
consumer research purposes, it is valid
and meaningful to include these terms
and product-risk relationships as a
measure of consumer product
inferences.
(Comment 6) A comment questioned
the relevance of a series of Study 1
questions related to participants’
inferences of what health conditions to
which a product may be related. The
comment explained that these questions
are not consistent with established
policy regarding health claims.
(Response) We understand and
acknowledge this concern. Upon further
consideration of the purposes of the
study and the time length of the
40155
interview, we have revised the content
of the study and removed the questions
the comment discussed.
(Comment 7) A comment made
several editorial suggestions and
clarifications to the proposed
questionnaires. For example, the
comment suggested that ‘‘lesser amount
of fat’’ in one Study 1 question be
corrected grammatically, that ‘‘if you are
allowed to eat xx g of carbohydrate as
a snack’’ in another Study 1 question be
revised to say ‘‘if you wish to eat a food
with xx g of carbohydrate as a snack.’’
The comment also asked that Study 2
clarify that the participants can select
multiple items in a product category
and revise the wording in one question
to reflect this. The comment further
asked that Study 2 clarify that the
interviewer will escort the participants
to the store aisle for the target product
category.
(Response) We have considered and
incorporated the suggestions, when
appropriate, in the revised
questionnaires. For example, in Study 1
we did not make the suggested
correction on ‘‘less amount of fat’’ or the
suggested revision on carbohydrate.
Instead, being mindful of the length of
the study instrument, these questions
were removed and replaced with other
questions. At the same time, we have
made the two clarifications in Study 2.
(Comment 8) A comment suggested
that we make the label and package
designs available for public review.
(Response) We have included the
label and package designs in the
supporting statement.
FDA estimates the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Activity
Number of
respondents
Number of
responses per
respondent
Total annual
responses
Average burden
per response
Laboratory pretest invitation .............
Laboratory pretest .............................
Laboratory study invitation ................
Laboratory study ...............................
In-store study invitation .....................
In-store study ....................................
Total ...........................................
30
15
500
200
300
60
........................
1
1
1
1
1
1
........................
30
15
500
200
300
60
........................
0.033 (2 minutes) .............................
1 .......................................................
0.033 (2 minutes) .............................
0.333 (20 minutes) ...........................
0.083 (5 minutes) .............................
0.75 (45 minutes) .............................
...........................................................
emcdonald on DSK67QTVN1PROD with NOTICES
1
Total hours
1
15
17
67
25
45
170
There are no capital costs or operating and maintenance costs associated with this collection of information.
II. References
The following references have been
placed on display in the Division of
Dockets Management (HFA–305), Food
and Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852,
and may be seen by interested persons
between 9 a.m. and 4 p.m., Monday
VerDate Mar<15>2010
17:48 Jul 02, 2013
Jkt 229001
through Friday, and are available
electronically at https://
www.regulations.gov. (FDA has verified
all the Web site addresses in this
reference section, but we are not
responsible for any subsequent changes
to the Web sites after this document
publishes in the Federal Register.)
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
1. Jones, G. and M. Richardson, ‘‘An
Objective Examination of Consumer
Perception of Nutrition Information Based on
Healthiness Ratings and Eye Movements,’’
Public Health Nutrition, vol. 10, pp. 238–244,
2007.
2. Bialkova, S. and H. C. M. van Trijp,
‘‘What Determines Consumer Attention to
Nutrition Labels?’’ Food Quality and
Preference, vol. 21, pp. 1042–1051, 2010.
E:\FR\FM\03JYN1.SGM
03JYN1
40156
Federal Register / Vol. 78, No. 128 / Wednesday, July 3, 2013 / Notices
3. van Herpen, E. and H. C. M. van Trijp,
‘‘Front-of-Pack Nutrition Labels, Their Effect
on Attention and Choices When Consumers
Have Varying Goals and Time Constraints,’’
Appetite, vol. 57, pp. 148–160, 2011.
4. Fox, R. J., D. M. Krugman, J. E. Fletcher,
and P. M. Fischer, ‘‘Adolescents’ Attention to
Beer and Cigarette Print Ads and Associated
Product Warnings,’’ Journal of Advertising,
vol. 27, pp. 57–68, 1998.
5. Galesic, M., R. Tourangeau, M. P.
Couper, and F. G. Conrad, ‘‘Eye-Tracking
Data: New Insights on Response Order Effects
and Other Cognitive Shortcuts in Survey
Responding,’’ Public Opinion Quarterly, vol.
72, pp. 892–913, 2008.
6. Graesser, A. C., Z. Cai, M. M. Louwerse,
and F. Daniel, ‘‘Question Understanding Aid
(QUAID): A Web Facility That Tests Question
Comprehensibility,’’ Public Opinion
Quarterly, vol. 70, pp. 3–22, 2006.
7. Reutskaja, E., R. Nagel, C. F. Camerer,
and A. Rangel, ‘‘Search Dynamics in
Consumer Choice Under Time Pressure: An
Eye-Tracking Study,’’ American Economic
Review, vol. 101, pp. 900–926, 2011.
8. FDA, ‘‘What We Do.’’ Available at
https://www.fda.gov/AboutFDA/WhatWeDo/
default.htm.
9. FDA, ‘‘Strengthen Social and Behavioral
Science to Help Consumers and Professionals
Make Informed Decisions About Regulated
Products,’’ Section 8 in Strategic Plan for
Regulatory Science. Available at https://
www.fda.gov/ScienceResearch/
SpecialTopics/RegulatoryScience/
ucm268150.htm.
Dated: June 25, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013–16001 Filed 7–2–13; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2013–N–0778]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Copy Testing of
the Food and Drug Administration’s
General Market Youth Tobacco
Prevention Campaigns
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the Agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal Agencies are required to
publish a notice in the Federal Register
concerning each proposed collection of
information and to allow 60 days for
public comment in response to the
emcdonald on DSK67QTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
17:48 Jul 02, 2013
Jkt 229001
notice. This notice solicits comments on
Copy Testing of FDA’s General Market
Youth Tobacco Prevention Campaigns.
Copy Testing of FDA’s General Market
Youth Tobacco Prevention Campaigns
(OMB Control Number—0910—New)
Submit either electronic or
written comments on the collection of
information by September 3, 2013.
The 2009 Family Smoking Prevention
and Tobacco Control Act (Tobacco
Control Act) (Public Law 111–31)
amends the Federal Food, Drug, and
Cosmetic Act (the FD&C Act) to grant
FDA authority to regulate the
manufacture, marketing, and
distribution of tobacco products to
protect public health and to reduce
tobacco use by minors. Section
1003(d)(2)(D) of the FD&C Act (21
U.S.C. 393(d)(2)(D)) supports the
development and implementation of
FDA public education campaigns
related to tobacco use. Accordingly,
FDA is currently developing and
implementing youth-targeted public
education campaigns to help prevent
tobacco use among youth and thereby
reduce the public health burden of
tobacco. The campaigns will feature
televised advertisements along with
complementary ads on radio, on the
Internet, in print, and through other
forms of media.
FDA requests OMB approval to collect
information needed to assess the
potential effectiveness of draft (or
‘‘rough-cut’’) youth tobacco prevention
campaign advertisements prior to
launch. This information will be
collected through copy testing as part of
the message development phase. Copy
testing involves showing rough-cut
versions of campaign advertisements to
a small sample of the campaign target
audience to ensure understanding of
messages and assess any potential
unintended consequences. Copy testing
of FDA’s rough-cut general market
youth tobacco prevention campaign
advertisements is needed to ensure
development and execution of
meaningful and effective public
education tactics.
FDA plans to conduct three voluntary
cross-sectional studies involving youth
ages 12 to 17 to copy test the Agency’s
general market youth tobacco
prevention campaign advertisements:
1. Youth Experimenter Copy Testing:
The study will be designed to obtain
insights into potential effectiveness and
unintended consequences of
advertisements designed to target
general market youth ages 12–17 who
are currently experimenting with
tobacco products (i.e., have smoked
between 1 and 100 cigarettes).
2. Youth Non-Trier Copy Testing: The
study will be designed to obtain insights
into potential effectiveness and
unintended consequences of
advertisements designed to target
general market youth ages 12–17 who
DATES:
Submit electronic
comments on the collection of
information to https://
www.regulations.gov. Submit written
comments on the collection of
information to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. All
comments should be identified with the
docket number found in brackets in the
heading of this document.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Daniel Gittleson, Office of Information
Management, Food and Drug
Administration, 1350 Piccard Dr., PI50–
400B, Rockville, MD 20850, 301–796–
5156, daniel.gittleson@fda.hhs.gov.
Under the
PRA (44 U.S.C. 3501–3520), Federal
Agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
Agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
comments on these topics: (1) Whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques,
when appropriate, and other forms of
information technology.
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
E:\FR\FM\03JYN1.SGM
03JYN1
Agencies
[Federal Register Volume 78, Number 128 (Wednesday, July 3, 2013)]
[Notices]
[Pages 40153-40156]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-16001]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2012-N-0593]
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Eye Tracking
Experimental Studies To Explore Consumer Use of Food Labeling
Information and Consumer Response to Online Surveys
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or we) is announcing
that a proposed collection of information has been submitted to the
Office of Management and Budget (OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the collection of information by August
2, 2013.
ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
FAX: 202-395-7285, or emailed to oira_submission@omb.eop.gov. All
comments should be identified with the OMB control number 0910-New and
title ``Eye Tracking Experimental Studies to Explore Consumer Use of
Food Labeling Information and Consumer Response to Online Surveys.''
Also include the FDA docket number found in brackets in the heading of
this document.
FOR FURTHER INFORMATION CONTACT: Domini Bean, Office of Information
Management, Food and Drug Administration, 1350 Piccard Dr., PI50-400T,
Rockville, MD 20850, domini.bean@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.
Eye Tracking Experimental Studies To Explore Consumer Use of Food
Labeling Information and Consumer Response to Online Surveys--(OMB
Control Number 0910-NEW)
I. Background
Eye tracking is a consumer research technique often used to
determine where a person is looking while interacting with a visual
display, such as a product package and elements of information on the
package. The technique collects eye movement data, i.e., fixations and
saccades (jumps of the eye), which may be superimposed on the display
image to reveal: (1) Which parts of the display captured the viewer's
attention, (2) the order and path in which visual elements were seen,
and (3) the length of time they were viewed. These data provide
detailed information on what individuals pay attention to on product
packages, how long they spend looking at different package elements,
and how visual attention may be related to their reaction to the images
(Refs. 1 to 4, 7). Data from eye tracking studies can also help improve
questionnaire design. Different respondents may pay differing degrees
of attention to the elements of a survey question or response options.
Eye tracking data can help to identify the need and strategies for
improving the design (Refs. 5 and 6). Finally, eye tracking data can
provide information on the decision strategies that individuals use
under different levels of time pressure, which can help reveal the
influence of time on busy individuals' food choices (Refs. 4 and 7).
As a public health agency, FDA helps consumers make informed
dietary decisions by regulating nutrition information on food labels,
among other activities. An understanding of how visual elements (e.g.,
labeling statements such as claims, disclosure statements, logos, and
Nutrition Facts label) influence consumers' perceptions and choices of
products can assist us in developing labeling information to help
consumers make informed dietary decisions. In addition, we use self-
administered questionnaires in online experimental studies to assess
consumer reactions to nutrition information on food packages. An
understanding of how respondents react to survey materials that are
presented visually will enhance our ability in collecting better
consumer data to help us fulfill our missions.
The proposed data collection will use eye tracking research to
examine consumers' eye movements to achieve three goals: (1) To better
understand consumer reaction to specific food labeling information, (2)
to better understand survey respondent reaction to specific survey
questions related to nutrition and health, and (3) to better understand
how time pressure influences the priority and quality of decision
making and survey response. In order to observe consumers' eye movement
in different types of settings, we propose to conduct two separate
studies, one in each of two different settings. Study 1 is a laboratory
study that will ask participants to view on a computer screen mockups
of food labels and perform tasks as well as answer other survey
questions. Study 2 is an in-store study that will record eye movement
data from grocery shoppers while they shop for preselected product
categories. The studies will use two different survey instruments.
Study participants will come from two separate convenience samples.
A. Study 1 (Laboratory Study)
Study 1 is a controlled randomized experiment. It has two
objectives. The first objective is to collect data on how consumers
view and process label information. The data will be used to test the
hypothesis that one or more label and information characteristics will
cause variations in viewing and processing. In this proposed study, we
will focus specifically on the following characteristics: (1) Presence
and type of nutrition symbols, together with presence of claims, on the
Principal Display Panel (PDP) of a conventional food; (2) presence of a
disclosure statement (21 CFR 101.13(h)(1)-(3)) on the PDP of a
conventional food that makes a nutrient content claim; (3) format of
the Nutrition Facts label on a conventional food product; (4) presence
of a Dietary Supplement Health and Education Act disclaimer on the PDP
of
[[Page 40154]]
a dietary supplement product that makes a structure/function claim; (5)
presence and length of a qualified health claim on the PDP of a dietary
supplement product; and (6) type of product.
Label images will be created to allow the study to focus on
consumer reaction to specific components of information on a food
label. All images will be mockups resembling food labels that may be
found in the marketplace but without any real or fictitious brand name.
The second objective of Study 1 is to examine how time pressure
affects information processing. We will use the data to test the
hypothesis that time pressure will cause variations in participant
reactions (notice, attention, use, perception, and intention) to
information. To test this hypothesis, the study will, at certain
selected questions, expose participants to two randomly assigned time
conditions, such as no time limit and 10 seconds per question.
The study will also include certain questions selected from
previous online research we have sponsored in order to examine which
part(s) of a question or which response options participants notice and
pay attention to when they are asked to answer the question.
In the study, we plan to collect data from 200 participants using a
15-minute computer-assisted self-administered questionnaire and a 5-
minute debriefing questionnaire. Forty interviews are planned for each
of 5 locations across the contiguous 48 States. Participants will be
recruited from residents at each location, and the study will aim to
have a reasonable degree of diversity in participant gender, age, and
education. On a computer screen, participants will first view a series
of label images. Then participants will answer a set of questions
related to their reactions to the label images they see on the computer
screen. Each participant will be randomly assigned to an experimental
condition that differs primarily in label components and time limit. To
help understand the data, the study will also collect information on
each participant's background, such as health status, label reading
behavior, and dietary preferences.
B. Study 2 (In-Store Study)
In Study 2, we plan to collect observations of what information
grocery shoppers notice and pay attention to while they do their
shopping in the store. The study will gather eye movement data to
provide an indepth understanding of subconscious and conscious factors
that influence food purchases. Specifically, the study will explore the
role that the Principal Display Panel and other label information and
components play in purchase decisions. We will use the data to test the
hypotheses that product familiarity or personal needs will cause
variations in information seeking and that design elements (e.g.,
prominence, text vs. graphics) will cause variations in information
seeking. To keep the study within a manageable scope, only shoppers who
plan to shop for one or more of preselected product categories will be
eligible to participate. Other than product categories, however,
participants will not be restricted to which products they examine,
what label information they view, or how much time they spend in
completing any part of the study. To help understand the data, the
study will also collect information on each participant's background,
such as health status and shopping practices. In Study 2 we plan to
collect data from 60 participants who will each spend an average of 45
minutes in the study, including a practice session, the shopping trip,
and a debriefing. The study will be conducted in two different
locations. Participants will be recruited at storefronts.
Both the laboratory study (Study 1) and the in-store study (Study
2) are part of our continuing effort to enable consumers to make
informed dietary choices. We will use the studies to assess consumer
attention to and use of various pieces of information on food packages
and the information's influence on product perceptions and choices. The
assessment will provide us with background information to help identify
and develop more effective labeling information and education in the
future. In addition, we will use data from Study 1 to assess consumer
behaviors when they are asked to respond to a sample of questions used
in the Agency's consumer research. The assessment will help enhance our
ability to conduct research that provides useful information. Wherever
possible, we will also attempt to compare findings from the two studies
to assess the degree to which results observed in the laboratory
reflect actual behaviors in the market. For example, do laboratory and
in-store participants pay attention to different labeling elements when
they make a shopping choice? Results of the study will not be used to
develop population estimates.
In the Federal Register of June 15, 2012 (77 FR 35983), FDA
published a 60-day notice requesting public comment on the proposed
collection of information. We received three comments. One comment
addressed matters that were outside the scope of the information
collection provisions and will not be discussed here. We respond to the
remaining comments in this document. For ease of reading, we preface
each comment with a numbered ``Comment;'' and each response by a
corresponding ``Response.'' We have numbered each comment to help
distinguish between different topics. The number assigned to each
comment is for organizational purposes only and does not signify the
comment's value, or importance, or the order in which it was received.
(Comment 1) One comment recommended that we examine the accuracy of
the eye tracking methodology in identifying label reading patterns
before considering applying the methodology more broadly.
(Response) FDA agrees that it is important to assess the degree of
accuracy the methodology can provide and we have taken this into
consideration.
(Comment 2) One comment questioned whether the use of eye tracking
methodology is essential to the regulation of food labeling.
(Response) Part of our mission is to help the public get accurate
and science-based information needed to use foods to maintain and
improve health (Ref. 8). To help accomplish this mission, we state in
our 2011-2015 Strategic Plan that we will strengthen social and
behavioral sciences to help consumers make informed decisions about
regulated products (Ref. 9). As part of the strategy, the plan
identifies needs in knowing the audience, ensuring audience
understanding of information, and evaluating effectiveness of
communication about regulated products (Ref. 9). We will use the
proposed studies to assess consumer attention to and use of various
pieces of information on food packages and the information's influence
on product perceptions and choices. These findings can extend and
compliment findings from other consumer research FDA conducts and help
us identify and develop more effective food labeling information and
education in the future. Therefore, the use of eye tracking methodology
is valuable to our mission in providing the public accurate and
science-based information.
(Comment 3) One comment questioned the practical utility of the
information to be collected in the proposed studies. The comment stated
that Study 1 would not yield nationally representative results because
it uses a convenience sample and suggests this limitation be noted in
the supporting
[[Page 40155]]
statement accompanying the Federal Register 30-day notice. The comment
also questioned whether the sample size of Study 2 (60 participants)
would be sufficient to yield detailed conclusions.
(Response) The 60-day notice stated that the studies would not be
used to develop national estimates. We repeat this statement in the
supporting statement. Though the sample size of Study 2 is constrained
by the available resource, the study will provide preliminary yet
useful insights into consumer viewing experiences with food shopping.
(Comment 4) A comment asserted that wearing eye tracking eyeglasses
and a headset for biometric measurement in Study 2 would cause study
subjects to behave differently from how they shop typically, thus
weakening the reliability of the data. Instead, the comment suggests
using a virtual store methodology in a computer-assisted central
location test.
(Response) The comment did not provide evidence to support its
concern or to illustrate the advantages of a virtual store methodology
over an eye tracking methodology. Therefore, because we do not have a
sufficient basis to conclude that the comment's suggested methodology
would be better suited for our purposes than the eye tracking
methodology described in the 60-day notice, we decline to change the
methodology for Study 2.
(Comment 5) A comment questioned the use of the word ``healthy'' in
certain questions because the word has a regulatory meaning and
consumers may not understand the regulatory criteria for the claim
``healthy.'' The comment suggested replacing ``healthy'' with
``nutritious.'' The comment also expressed concern about questions that
ask participants their inferences about the relationships between a
product and the risk of diabetes and obesity or overweight. The comment
reasoned that these health conditions should not be asked about because
there are no current authorized health claims permitted for these
conditions.
(Response) We disagree with the comment. The studies are not to
examine whether or how consumers understand labeling regulations.
Rather, part of the purpose of the studies is to better understand how
consumers infer from labeling the characteristics of food products. As
stated in the comment, consumers may not understand regulatory criteria
for claims, including ``healthy,'' and there are no authorized health
claims that link a food to diabetes or obesity. Yet consumers make
product inferences and decisions based on their own experiences and
knowledge, with or without any understanding about labeling
regulations. Hence, for consumer research purposes, it is valid and
meaningful to include these terms and product-risk relationships as a
measure of consumer product inferences.
(Comment 6) A comment questioned the relevance of a series of Study
1 questions related to participants' inferences of what health
conditions to which a product may be related. The comment explained
that these questions are not consistent with established policy
regarding health claims.
(Response) We understand and acknowledge this concern. Upon further
consideration of the purposes of the study and the time length of the
interview, we have revised the content of the study and removed the
questions the comment discussed.
(Comment 7) A comment made several editorial suggestions and
clarifications to the proposed questionnaires. For example, the comment
suggested that ``lesser amount of fat'' in one Study 1 question be
corrected grammatically, that ``if you are allowed to eat xx g of
carbohydrate as a snack'' in another Study 1 question be revised to say
``if you wish to eat a food with xx g of carbohydrate as a snack.'' The
comment also asked that Study 2 clarify that the participants can
select multiple items in a product category and revise the wording in
one question to reflect this. The comment further asked that Study 2
clarify that the interviewer will escort the participants to the store
aisle for the target product category.
(Response) We have considered and incorporated the suggestions,
when appropriate, in the revised questionnaires. For example, in Study
1 we did not make the suggested correction on ``less amount of fat'' or
the suggested revision on carbohydrate. Instead, being mindful of the
length of the study instrument, these questions were removed and
replaced with other questions. At the same time, we have made the two
clarifications in Study 2.
(Comment 8) A comment suggested that we make the label and package
designs available for public review.
(Response) We have included the label and package designs in the
supporting statement.
FDA estimates the burden of this collection of information as
follows:
Table 1--Estimated Annual Reporting Burden \1\
----------------------------------------------------------------------------------------------------------------
Number of
Activity Number of responses per Total annual Average burden Total hours
respondents respondent responses per response
----------------------------------------------------------------------------------------------------------------
Laboratory pretest invitation. 30 1 30 0.033 (2 1
minutes).
Laboratory pretest............ 15 1 15 1............... 15
Laboratory study invitation... 500 1 500 0.033 (2 17
minutes).
Laboratory study.............. 200 1 200 0.333 (20 67
minutes).
In-store study invitation..... 300 1 300 0.083 (5 25
minutes).
In-store study................ 60 1 60 0.75 (45 45
minutes).
Total..................... .............. .............. .............. ................ 170
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
information.
II. References
The following references have been placed on display in the
Division of Dockets Management (HFA-305), Food and Drug Administration,
5630 Fishers Lane, Rm. 1061, Rockville, MD 20852, and may be seen by
interested persons between 9 a.m. and 4 p.m., Monday through Friday,
and are available electronically at https://www.regulations.gov. (FDA
has verified all the Web site addresses in this reference section, but
we are not responsible for any subsequent changes to the Web sites
after this document publishes in the Federal Register.)
1. Jones, G. and M. Richardson, ``An Objective Examination of
Consumer Perception of Nutrition Information Based on Healthiness
Ratings and Eye Movements,'' Public Health Nutrition, vol. 10, pp.
238-244, 2007.
2. Bialkova, S. and H. C. M. van Trijp, ``What Determines
Consumer Attention to Nutrition Labels?'' Food Quality and
Preference, vol. 21, pp. 1042-1051, 2010.
[[Page 40156]]
3. van Herpen, E. and H. C. M. van Trijp, ``Front-of-Pack
Nutrition Labels, Their Effect on Attention and Choices When
Consumers Have Varying Goals and Time Constraints,'' Appetite, vol.
57, pp. 148-160, 2011.
4. Fox, R. J., D. M. Krugman, J. E. Fletcher, and P. M. Fischer,
``Adolescents' Attention to Beer and Cigarette Print Ads and
Associated Product Warnings,'' Journal of Advertising, vol. 27, pp.
57-68, 1998.
5. Galesic, M., R. Tourangeau, M. P. Couper, and F. G. Conrad,
``Eye-Tracking Data: New Insights on Response Order Effects and
Other Cognitive Shortcuts in Survey Responding,'' Public Opinion
Quarterly, vol. 72, pp. 892-913, 2008.
6. Graesser, A. C., Z. Cai, M. M. Louwerse, and F. Daniel,
``Question Understanding Aid (QUAID): A Web Facility That Tests
Question Comprehensibility,'' Public Opinion Quarterly, vol. 70, pp.
3-22, 2006.
7. Reutskaja, E., R. Nagel, C. F. Camerer, and A. Rangel,
``Search Dynamics in Consumer Choice Under Time Pressure: An Eye-
Tracking Study,'' American Economic Review, vol. 101, pp. 900-926,
2011.
8. FDA, ``What We Do.'' Available at https://www.fda.gov/AboutFDA/WhatWeDo/default.htm.
9. FDA, ``Strengthen Social and Behavioral Science to Help
Consumers and Professionals Make Informed Decisions About Regulated
Products,'' Section 8 in Strategic Plan for Regulatory Science.
Available at https://www.fda.gov/ScienceResearch/SpecialTopics/RegulatoryScience/ucm268150.htm.
Dated: June 25, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013-16001 Filed 7-2-13; 8:45 am]
BILLING CODE 4160-01-P